In this interview with Trisha Peel from Monash University, she explains the issues surrounding device-related infections in addition to discussing some promising new approaches to diagnosis and treatment.
Browsing: Clinical > Clinical Diseases
Merck’s antibiotic ZERBAXA® (ceftolozane and tazobactam) has met its primary endpoint of non-inferiority compared with meropenem in a Phase III trial of patients with hospital-acquired and ventilator-associated bacterial pneumonia.
We speak to infectious diseases specialist, Ellie Goldstein (Santa Monica, CA, USA), about his recent publication on real world data and the challenges facing drug-resistant infections.
A study in 20 patients has demonstrated that transplantation followed by antiviral therapy has been successful in patients receiving kidneys from hepatitis C-infected donors.
Whole-genome sequencing has been used to demonstrate that carbapenem resistance can be transferred among unrelated bacteria species in a healthcare setting.
Trends in Acinetobacter baumannii infections, one of the most prevalent hospital-acquired infections in children, have been studied revealing that both cephalosporin and carbapenem resistance has increased.
To celebrate International Nurses Day we spoke to Helen Bosley, Infection Prevention and Control Matron at Oxford Health NHS Foundation Trust about her responsibilities, her daily routine and her hobbies.
With May 12 marking International Nurses Day we spoke to Leila Hail, Senior Clinical Nurse Specialist in Infection Control at University College Hospital, about her responsibilities, the challenges she faces and an incident involving alcohol gel!
Using contact precautions in addition the to the basic level of infection control might not limit the spread of drug-resistant Enterobacteriaceae, according to work presented at ECCMID.
World TB Day has seen the launch of the N-TB app, a first-of-kind tool to help healthcare providers in the nutritional assessment and counselling of adult patients with tuberculosis.